{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:53:26Z","timestamp":1780631606491,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T00:00:00Z","timestamp":1096070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00277-004-0953-9","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T16:23:54Z","timestamp":1096043034000},"page":"118-121","source":"Crossref","is-referenced-by-count":19,"title":["Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options"],"prefix":"10.1007","volume":"84","author":[{"given":"Dirk","family":"H\ufffdnemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,25]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(85)92930-7","volume":"2","author":"PG Isaacson","year":"1985","unstructured":"Isaacson PG, O?Connor NT, Spencer J et al (1985) Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 2:688?691","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"A Lopez-Guillermo","year":"1998","unstructured":"Lopez-Guillermo A, Cid J, Salar A et al (1998) Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol 9:849?855","journal-title":"Ann Oncol"},{"key":"CR3","first-page":"493","volume":"151","author":"M Ashton-Key","year":"1997","unstructured":"Ashton-Key M, Diss TC, Pan L et al (1997) Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 151:493?498","journal-title":"Am J Pathol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","volume":"92","author":"F Carbonnel","year":"1998","unstructured":"Carbonnel F, Grollet-Bioul L, Brouet JC et al (1998) Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 92:3879?3886","journal-title":"Blood"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","volume":"287","author":"C Catassi","year":"2002","unstructured":"Catassi C, Fabiani E, Corrao G et al (2002) Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287:1413?1419","journal-title":"JAMA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gut.30.3.333","volume":"30","author":"GK Holmes","year":"1989","unstructured":"Holmes GK, Prior P, Lane MR et al (1989) Malignancy in coeliac disease?effect of a gluten free diet. Gut 30:333?338","journal-title":"Gut"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/gut.35.9.1215","volume":"35","author":"P Collin","year":"1994","unstructured":"Collin P, Reunala T, Pukkala E et al (1994) Coeliac disease?associated disorders and survival. Gut 35:1215?1218","journal-title":"Gut"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","volume":"362","author":"PH Green","year":"2003","unstructured":"Green PH, Jabri B (2003) Coeliac disease. Lancet 362:383?391","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","volume":"346","author":"RJ Farrell","year":"2002","unstructured":"Farrell RJ, Kelly CP (2002) Celiac sprue. N Engl J Med 346:180?188","journal-title":"N Engl J Med"},{"key":"CR10","first-page":"687","volume":"36","author":"S Bevan","year":"1999","unstructured":"Bevan S, Popat S, Braegger CP et al (1999) Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 36:687?690","journal-title":"J Med Genet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.50.5.624","volume":"50","author":"L Greco","year":"2002","unstructured":"Greco L, Romino R, Coto I et al (2002) The first large population based twin study of coeliac disease. Gut 50:624?628","journal-title":"Gut"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","volume":"356","author":"C Cellier","year":"2000","unstructured":"Cellier C, Delabesse E, Helmer C et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356:203?208","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.1506","volume":"202","author":"EC Obermann","year":"2004","unstructured":"Obermann EC, Diss TC, Hamoudi RA et al (2004) Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma. J Pathol 202:252?262","journal-title":"J Pathol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A et al (2002) Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 161:1635?1645","journal-title":"Am J Pathol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.1997.2660862.x","volume":"31","author":"PC Bruin de","year":"1997","unstructured":"de Bruin PC, Connolly CE, Oudejans JJ et al (1997) Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype. Histopathology 31:313?317","journal-title":"Histopathology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00918857","volume":"12","author":"S Gupta","year":"1992","unstructured":"Gupta S, Kim CH, Tsuruo T, Gollapudi S (1992) Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol 12:451?458","journal-title":"J Clin Immunol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","volume":"18","author":"J Gale","year":"2000","unstructured":"Gale J, Simmonds PD, Mead GM et al (2000) Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 18:795?803","journal-title":"J Clin Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","volume":"21","author":"LJ Egan","year":"1995","unstructured":"Egan LJ, Walsh SV, Stevens FM et al (1995) Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 21:123?129","journal-title":"J Clin Gastroenterol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2003.06.026","volume":"21","author":"S Daum","year":"2003","unstructured":"Daum S, Ullrich R, Heise W et al (2003) Intestinal non-Hodgkin?s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin?s Lymphoma. J Clin Oncol 21:2740?2746","journal-title":"J Clin Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O?Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18:547?561","journal-title":"J Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","volume":"27","author":"AK Blystad","year":"2001","unstructured":"Blystad AK, Enblad G, Kvaloy S et al (2001) High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 27:711?716","journal-title":"Bone Marrow Transplant"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704367","volume":"33","author":"E Jantunen","year":"2004","unstructured":"Jantunen E, Wiklund T, Juvonen E et al (2004) Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplant 33:405?410","journal-title":"Bone Marrow Transplant"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J Rodriguez","year":"2001","unstructured":"Rodriguez J, Munsell M, Yazji S et al (2001) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 19:3766?3770","journal-title":"J Clin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","volume":"14","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A et al (2003) High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 14:1768?1775","journal-title":"Ann Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/1042819031000123456","volume":"44","author":"E Jantunen","year":"2003","unstructured":"Jantunen E, Juvonen E, Wiklund T et al (2003) High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. Leuk Lymphoma 44:2163?2164","journal-title":"Leuk Lymphoma"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/978-3-642-57054-4_10","volume":"156","author":"I Buchmann","year":"2000","unstructured":"Buchmann I, Moog F, Schirrmeister H, Reske SN (2000) Positron emission tomography for detection and staging of malignant lymphoma. Recent Results Cancer Res 156:78?89","journal-title":"Recent Results Cancer Res"},{"key":"CR27","first-page":"3572","volume":"102","author":"PN Mollee","year":"2003","unstructured":"Mollee PN, Mills AK, Grimmett K et al (2003) The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies. Blood 102:3572","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-0953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-004-0953-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-0953-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:51:32Z","timestamp":1585893092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-004-0953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s00277-004-0953-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,25]]}}}